Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.97 USD
Change Today +0.01 / 0.17%
Volume 129.3K
NEO On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 4:30 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - neogenomics inc (NEO)

Name (Connections)Board RelationshipsTitleKey Developments
Raymond Hipp 17 RelationshipsIndependent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance CommitteeNeogenomics Inc. announced delayed 10-Q filing
11/16/09
Kevin Johnson 18 RelationshipsIndependent Director, Member of Audit Committee, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Compliance CommitteeNeogenomics Inc. announced delayed annual 10-K filing
03/31/09
Bruce Crowther 33 RelationshipsDirector, Member of Audit Committee and Member of Compliance CommitteeNeogenomics Inc. Restates Earnings Results for the Year Ended December 31, 2007
04/15/08

Compensation Committee* - neogenomics inc (NEO)

Name (Connections)Board RelationshipsTitle
Raymond Hipp 17 RelationshipsIndependent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Kevin Johnson 18 RelationshipsIndependent Director, Member of Audit Committee, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Compliance Committee
William Robison 26 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Lynn Tetrault 7 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
NEO Compensation vs. Industry
441.3K
413.3K
Chief Executive Officer
266.5K
310.5K
Chief Financial Officer
68.8K
361.7K
Chief Operating Officer
Share price activity for NEOGENOMICS INC (NEO)
52 Week Price Performance
NEO
Industry Average

Nominating Committee* - neogenomics inc (NEO)

Name (Connections)Board RelationshipsTitleKey Developments
William Robison 26 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance CommitteeNeogenomics Inc. Announces New Directors
06/17/15
Raymond Hipp 17 RelationshipsIndependent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance CommitteeNeogenomics Announces Promotions of Senior Management Team
04/23/15
Lynn Tetrault 7 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Compensation CommitteeNeoGenomics, Inc. Announces Executive Changes
04/21/15
Kevin Johnson 18 RelationshipsIndependent Director, Member of Audit Committee, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Compliance CommitteeNeogenomics Inc. Appoints Bruce Crowther as Member of the Board
10/27/14

Corporate Governance Committee* - neogenomics inc (NEO)

Name (Connections)Board RelationshipsTitle
Raymond Hipp 17 RelationshipsIndependent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Kevin Johnson 18 RelationshipsIndependent Director, Member of Audit Committee, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Compliance Committee
William Robison 26 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Lynn Tetrault 7 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
NEO and Competitor
Insiders vs. External
Board
25%
75%
Neogenomics Inc.
60%
40%
Enzo Biochem Inc.
25%
75%
Psychemedics Corp.
11%
89%
Rosetta Genomics, Ltd.
14%
86%
Response Genetics, Inc
14%
86%
Cancer Genetics, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $5.97 USD +0.01

NEO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cancer Genetics Inc $10.21 USD +0.14
Enzo Biochem Inc $3.02 USD +0.02
Psychemedics Corp $11.73 USD -0.38
Response Genetics Inc $0.13 USD -0.02
Rosetta Genomics Ltd $3.09 USD -0.03
View Industry Companies
 

Industry Analysis

NEO

Industry Average

Valuation NEO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.8x
Price/Book 6.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGENOMICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.